Tropomyosin receptor kinase C (TrkC), also known as NT-3 growth factor receptor, neurotrophic tyrosine kinase receptor type 3, or TrkC tyrosine kinase is a protein that in humans is encoded by the NTRK3gene.
TrkC is part of a sub-family of protein kinases which includes TrkA and TrkB. Also, there are other neurotrophic factors structurally related to NT-3: NGF (for Nerve Growth Factor), BDNF (for Brain Derived Neurotrophic Factor) and NT-4 (for Neurotrophin-4). While TrkB mediates the effects of BDNF, NT-4 and NT-3, TrkA is bound and thereby activated only by NGF. Further, TrkC binds and is activated only by NT-3.
TrkB binds BDNF and NT-4 more strongly than it binds NT-3. TrkC binds NT-3 more strongly than TrkB does.
There is one other NT-3 receptor family besides the Trks (TrkC & TrkB), called the "LNGFR" (for "low affinity nerve growth factor receptor"). As opposed to TrkC, the LNGFR plays a somewhat less clear role in NT-3 biology. Some researchers have shown the LNGFR binds and serves as a "sink" for neurotrophins. Cells which express both the LNGFR and the Trk receptors might therefore have a greater activity - since they have a higher "microconcentration" of the neurotrophin. It has also been shown, however, that the LNGFR may signal a cell to die via apoptosis - so therefore cells expressing the LNGFR in the absence of Trk receptors may die rather than live in the presence of a neurotrophin.
^Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 8: Atypical neurotransmitters". In Sydor A, Brown RY. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). New York: McGraw-Hill Medical. pp. –. ISBN9780071481274. Another common feature of neurotrophins is that they produce their physiologic effects by means of the tropomyosin receptor kinase (Trk) receptor family (also known as the tryosine receptor kinase family). ...
All neurotrophins bind to a class of highly homologous receptor tyrosine kinases known as Trk receptors, of which three types are known: TrkA, TrkB, and TrkC. These transmembrane receptors are glycoproteins whose molecular masses range from 140 to 145 kDa. Each type of Trk receptor tends to bind specific neurotrophins: TrkA is the receptor for NGF, TrkB the receptor for BDNF and NT-4, and TrkC the receptor for NT-3.However, some overlap in the specificity of these receptors has been noted.
^McGregor LM, Baylin SB, Griffin CA, Hawkins AL, Nelkin BD (July 1994). "Molecular cloning of the cDNA for human TrkC (NTRK3), chromosomal assignment, and evidence for a splice variant". Genomics22 (2): 267–72. doi:10.1006/geno.1994.1383. PMID7806211.
Tessarollo L, Tsoulfas P, Martin-Zanca D et al. (1993). "trkC, a receptor for neurotrophin-3, is widely expressed in the developing nervous system and in non-neuronal tissues". Development118 (2): 463–75. PMID8223273.CS1 maint: Explicit use of et al. (link)
Klein R, Silos-Santiago I, Smeyne RJ et al. (1994). "Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements". Nature368 (6468): 249–51. doi:10.1038/368249a0. PMID8145824.CS1 maint: Explicit use of et al. (link)
Ip NY, Stitt TN, Tapley P et al. (1993). "Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells". Neuron10 (2): 137–49. doi:10.1016/0896-6273(93)90306-C. PMID7679912.CS1 maint: Explicit use of et al. (link)
Guiton M, Gunn-Moore FJ, Glass DJ et al. (1995). "Naturally occurring tyrosine kinase inserts block high affinity binding of phospholipase C gamma and Shc to TrkC and neurotrophin-3 signaling.". J. Biol. Chem.270 (35): 20384–90. doi:10.1074/jbc.270.35.20384. PMID7657612.CS1 maint: Explicit use of et al. (link)
Shelton DL, Sutherland J, Gripp J et al. (1995). "Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins.". J. Neurosci.15 (1 Pt 2): 477–91. PMID7823156.CS1 maint: Explicit use of et al. (link)
Pflug BR, Dionne C, Kaplan DR et al. (1995). "Expression of a Trk high affinity nerve growth factor receptor in the human prostate.". Endocrinology136 (1): 262–8. doi:10.1210/en.136.1.262. PMID7828539.CS1 maint: Explicit use of et al. (link)
Andersson B, Wentland MA, Ricafrente JY et al. (1996). "A "double adaptor" method for improved shotgun library construction.". Anal. Biochem.236 (1): 107–13. doi:10.1006/abio.1996.0138. PMID8619474.CS1 maint: Explicit use of et al. (link)
Yamamoto M, Sobue G, Yamamoto K et al. (1997). "Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues.". Neurochem. Res.21 (8): 929–38. doi:10.1007/BF02532343. PMID8895847.CS1 maint: Explicit use of et al. (link)
Valent A, Danglot G, Bernheim A (1997). "Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC(NTRK3) to human chromosomes 1q22, 9q22 and 15q25 by fluorescence in situ hybridization.". Eur. J. Hum. Genet.5 (2): 102–4. PMID9195161.
Knezevich SR, McFadden DE, Tao W et al. (1998). "A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma.". Nat. Genet.18 (2): 184–7. doi:10.1038/ng0298-184. PMID9462753.CS1 maint: Explicit use of et al. (link)
Urfer R, Tsoulfas P, O'Connell L et al. (1998). "High resolution mapping of the binding site of TrkA for nerve growth factor and TrkC for neurotrophin-3 on the second immunoglobulin-like domain of the Trk receptors.". J. Biol. Chem.273 (10): 5829–40. doi:10.1074/jbc.273.10.5829. PMID9488719.CS1 maint: Explicit use of et al. (link)